Exeter Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,522
| Closed | -$221K | – | 85 |
|
|
2022
Q3 | $221K | Sell |
7,522
-27,710
| -79% | -$814K | 0.13% | 84 |
|
|
2022
Q2 | $1.92M | Buy |
35,232
+1,560
| +5% | +$84.9K | 1.07% | 40 |
|
|
2022
Q1 | $1.83M | Buy |
33,672
+3,325
| +11% | +$181K | 0.99% | 43 |
|
|
2021
Q4 | $1.7M | Buy |
30,347
+3,400
| +13% | +$191K | 0.93% | 42 |
|
|
2021
Q3 | $1.29M | Sell |
26,947
-45
| -0.2% | -$2.15K | 0.77% | 45 |
|
|
2021
Q2 | $1.36M | Buy |
26,992
+368
| +1% | +$18.6K | 0.79% | 47 |
|
|
2021
Q1 | $1.19M | Buy |
26,624
+852
| +3% | +$38K | 0.75% | 49 |
|
|
2020
Q4 | $1.19M | Hold |
25,772
| – | – | 0.82% | 46 |
|
|
2020
Q3 | $1.21M | Buy |
25,772
+80
| +0.3% | +$3.77K | 0.95% | 41 |
|
|
2020
Q2 | $1.31M | Sell |
25,692
-1,653
| -6% | -$84.3K | 1.09% | 35 |
|
|
2020
Q1 | $1.3M | Buy |
27,345
+1,887
| +7% | +$89.4K | 1.22% | 32 |
|
|
2019
Q4 | $1.5M | Sell |
25,458
-960
| -4% | -$56.4K | 1.16% | 37 |
|
|
2019
Q3 | $1.41M | Hold |
26,418
| – | – | 1.12% | 37 |
|
|
2019
Q2 | $1.32M | Buy |
26,418
+400
| +2% | +$20K | 1.11% | 40 |
|
|
2019
Q1 | $1.36M | Sell |
26,018
-636
| -2% | -$33.2K | 1.18% | 38 |
|
|
2018
Q4 | $1.27M | Sell |
26,654
-400
| -1% | -$19.1K | 1.2% | 36 |
|
|
2018
Q3 | $1.36M | Buy |
27,054
+81
| +0.3% | +$4.07K | 1.12% | 39 |
|
|
2018
Q2 | $1.36M | Sell |
26,973
-446
| -2% | -$22.5K | 1.2% | 33 |
|
|
2018
Q1 | $1.34M | Buy |
27,419
+7,861
| +40% | +$384K | 1.15% | 36 |
|
|
2017
Q4 | $867K | Buy |
+19,558
| New | +$867K | 0.76% | 52 |
|